Pacira Pharmaceuticals buy Raymond James
Start price
31.07.24
/
50%
€19.10
Target price
31.07.25
€34.20
Performance (%)
-34.56%
Price
05.09.24
€13.10
Summary
This prediction is currently active. The BUY prediction by Raymond_James for Pacira Pharmaceuticals is performing very badly with a performance of -34.56%. This prediction currently runs until 31.07.25. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacira Pharmaceuticals | -5.072% | -5.072% |
iShares Core DAX® | -3.429% | 5.085% |
iShares Nasdaq 100 | -6.121% | 0.593% |
iShares Nikkei 225® | -7.364% | 5.479% |
iShares S&P 500 | -4.366% | 2.019% |
Comments by Raymond_James for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at Raymond James from $41.00 to $37.00. They now have an "outperform" rating on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by Raymond_James for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€29.60
20.12.23
20.12.23
€38.31
20.12.24
20.12.24
-57.77%
05.09.24
05.09.24